MedTrace Logo

HoPe: Home Treatment and Peer Support for Acute Mental Health Crisis

NCT04336527 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 201

Last updated 2023-05-31

No results posted yet for this study

Summary

Home treatment (HT) is an effective treatment modality for patients with severe mental illness (SMI) in acute crisis that can often be considered equivalent to inpatient treatment in terms of treatment outcome. In Peer Support (PS) patients are supported by people with personal experiences in psychiatric crises. The current study investigates a combination of both approaches - a HT plus PS intervention - versus sole HT at different study sites throughout Germany. It is hypothesized that a peer-supported home-delivered treatment (HT plus PS) is more effective than a professional-led home-delivered treatment (HT alone) with respect to the time until hospital readmission, self-efficacy, psychosocial health, recovery orientation, internalized stigma and service satisfaction. Furthermore, it is hypothesized, that a peer-supported home delivered treatment (HT plus PS) is as effective as a professional-led home-delivered treatment (HT alone) with respect to disease severity and general functioning (secondary outcomes).

Conditions

  • Severe Mental Health Condition With Indication of Hospital Admission

Interventions

BEHAVIORAL

Home Treatment with Peer Support

After allocation participants receive a combination of Home Treatment by a multiprofessional team and Peer Support.

BEHAVIORAL

Home Treatment without Peer Support

After allocation participants receive professional-led Home Treatment by a multiprofessional team without Peer Support (treatment as usual).

Sponsors & Collaborators

  • University of Ulm

    collaborator OTHER

  • Universitätsklinikum Hamburg-Eppendorf

    lead OTHER

Principal Investigators

  • Candelaria Mahlke, Dr. phil · Universitätsklinikum Hamburg-Eppendorf

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-21
Primary Completion
2023-08-31
Completion
2023-09-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04336527 on ClinicalTrials.gov